Welcome to our dedicated page for Clarivate Plc news (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate Plc stock.
Clarivate Plc (NYSE: CLVT) is described as a leading global provider of transformative intelligence, with news that reflects its activities across Academia & Government, Intellectual Property and Life Sciences & Healthcare. Company announcements frequently highlight new AI-powered tools, analytical reports and customer adoptions that illustrate how Clarivate combines enriched data, analytics and workflow software.
Recent news includes the launch of the Web of Science Research Assistant, a generative AI-powered tool that helps researchers conduct natural-language searches, perform literature reviews and explore visualizations based on more than 120 years of publication and citation data. Clarivate also reports on studies such as the Pulse of the Library report, which surveys thousands of librarians worldwide about AI adoption, open science and budget pressures, and on the annual Highly Cited Researchers list, which recognizes researchers whose work has had broad influence based on Web of Science data.
In Intellectual Property, Clarivate issues updates on solutions like IPfolio and Derwent Patent Monitor, including customer selections by organizations such as Nissan Motor Co., Ltd. and FUJIFILM Holdings Corporation. These stories emphasize how IP management platforms and AI-enabled patent review tools support more efficient IP operations and collaboration between IP and R&D teams.
Life sciences and healthcare news often centers on Clarivate analyses such as the Drugs to Watch report and Companies to Watch reports, which identify emerging therapies and innovative companies using integrated, AI-enhanced datasets. Visitors to this news page can follow Clarivate’s product launches, research reports, customer case studies and investor-related announcements to understand how the company is applying data and AI across its core markets.
Clarivate Plc (NYSE: CLVT) announced it will release its second quarter 2022 financial results on August 9, 2022, prior to market opening. The earnings report and financial details will be available on the investor website. A conference call and webcast to discuss the results will occur on the same day at 9:00 AM Eastern Time. Interested parties can join the call via a dedicated phone line or access the live webcast through the company’s investor relations site. A replay will be available for a limited time following the call.
Clarivate Plc (NYSE: CLVT) has been selected for the second consecutive time to provide citation data for the Australian Research Council's Excellence in Research for Australia (ERA) 2023. This initiative aims to evaluate research excellence across Australian universities. Utilizing The Web of Science™, Clarivate will support the ARC in assessing research quality through citation indicators and peer reviews. Clarivate has been involved with ERA since its inception in 2010, continually implementing improvements to enhance research evaluations.
Summary not available.
Clarivate Plc (NYSE: CLVT) has released its 2022 Journal Citation Reports (JCR), highlighting ongoing increases in citation impact for journals publishing COVID-19 research. Notably, The Lancet now holds the top Journal Impact Factor of 202.731, surpassing the New England Journal of Medicine, while Nature becomes the first journal to exceed one million citations in a year. The JCR assesses over 21,000 journals with rigorous criteria, emphasizing the profound influence of COVID-19 on academic publishing.
Clarivate Plc (NYSE: CLVT) announced that Jerre Stead and Jonathan Collins will present at investor conferences in June 2022. Key dates include the Stifel 2022 Cross Sector Insight Conference on June 7, 2022, at 9:10 AM ET, and the William Blair’s 42nd Annual Growth Stock Conference on June 9, 2022, at 2:20 PM ET. Live webcasts will be available for both events, with replays accessible afterwards. Clarivate aims to provide solutions that accelerate innovation across various sectors, including Life Sciences and Technology.
Summary not available.
Clarivate Plc (NYSE:CLVT; CLVT PR A) announced a quarterly dividend of $1.3125 per share on its 5.25% Series A Mandatory Convertible Preferred Shares. This dividend will be paid in cash on June 1, 2022, to shareholders of record as of May 13, 2022. This decision reflects the company's commitment to returning value to its shareholders while maintaining its focus on providing trusted information and insights that accelerate innovation.
Clarivate Plc (CLVT) reported strong financial results for Q1 2022, with revenues soaring to $662.2 million, a 54.6% increase year-over-year. Organic revenues rose 4.4%, while net income improved by $106.8 million to $50.8 million. Adjusted EBITDA also saw significant growth, up 59.2% to $262.3 million. Subscription revenues increased 69%, driven by the ProQuest acquisition. However, net cash provided by operating activities decreased by 61.3% to $67.4 million, primarily due to payroll payments. The company reaffirmed its positive outlook for 2022.
Clarivate Plc (NYSE:CLVT) released a new report detailing the evolving trademark landscape influenced by technological advancements like NFTs, metaverse, and cryptocurrency. Key findings reveal a nearly 9,000% increase in NFT-related trademark applications since 2018, with Class 9 filings rising to the second position globally in 2021. Despite overall growth in trademark filings for the 10th consecutive year, filings in Class 10 decreased by 22%. The report emphasizes the significance of intellectual property management in a competitive digital market.
Clarivate Plc (NYSE: CLVT) announced it will report its first quarter 2022 financial results on May 9, 2022, before market opens. Investors can access the press release and earnings supplement on the company's investor website at ir.clarivate.com.
A conference call and webcast will take place on the same day at 9:00 AM Eastern Time to discuss the results. Interested parties can join via phone or through the webcast link provided. An audio replay will be available shortly after the call, accessible until May 23, 2022.